JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jasmin, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jasmin, G.
Journal of Pharmacology And Experimental Therapeutics, Vol. 120, Issue 3, 349-353, 1957
Copyright © 1957 by American Society for Pharmacology and Experimental Therapeutics


PREVENTION OF EXPERIMENTAL POLYARTHRITIS WITH SODIUM AUROTHIOMALATE

Gaëtan Jasmin 1

1 Institut de Médicine et de Chirurgie expérimentales, Université de Montréal, Montréal, Canada

An experimental polyarthritis develops in rats following the intraperitoneal injection of 1 ml. of Murphy Rat Lymphosarcoma exudate. It was observed that gold therapy (Myochrysine) is equally effective in intact or adrenalectomized animals when the latter are maintained either on DOC-Ac or COL-Ac.

Nephroealcinosis resulting from massive treatment with myochrysine was evident on1y in adrenalectomized rats receeiving DOC-Ac. It is suggested that combined treatment of gold and COL-Ac might be beneficial as they both possess anti-inflammatory properties and the nephrotoxic action of gold is prevented by COL-Ac.

Submitted on February 11, 1957







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1957 by the American Society for Pharmacology and Experimental Therapeutics.